We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
+8.23%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$171B
AUM Growth
+$15.9B
(+10%)
Cap. Flow
-$4B
Cap. Flow
% of AUM
-2.34%
Top 10 Holdings %
Top 10 Hldgs %
24.19%
Holding
2,569
New
93
Increased
922
Reduced
1,343
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$1.13B |
| 2 |
Eli Lilly
LLY
|
+$554M |
| 3 |
Booking.com
BKNG
|
+$459M |
| 4 |
CSX Corp
CSX
|
+$363M |
| 5 |
Lowe's Companies
LOW
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$502M |
| 2 |
ASML
ASML
|
+$408M |
| 3 |
Teck Resources
TECK
|
+$383M |
| 4 |
Eaton
ETN
|
+$374M |
| 5 |
Uber
UBER
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.78% |
| 2 | Financials | 12.4% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Industrials | 10.06% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Heron Therapeutics
HRTX
$69.5M
| $26.3K | ﹤0.01% |
20,885
+2,863
| +16% | +$4.54K |
|
2352
Humacyte
HUMA
$193M
| $26.3K | ﹤0.01% |
15,097
+103
| +0.7% | +$202 |
|
2353
SmartRent
SMRT
$266M
| $26.1K | ﹤0.01% |
18,509
-1,874
| -9% | -$2.4K |
|
2354
Quantum-Si Incorporated
QSI
$176M
| $24.6K | ﹤0.01% |
17,476
+1,259
| +8% | +$1.82K |
|
2355
Codexis
CDXS
$161M
| $24.6K | ﹤0.01% |
+10,072
| New | +$27.5K |
|
|
LPRO
2356
DELISTED
Open Lending Corp
LPRO
| $24.2K | ﹤0.01% |
11,456
-1,495
| -12% | -$3.38K |
|
2357
Ironwood Pharmaceuticals
IRWD
$676M
| $23.6K | ﹤0.01% |
18,005
-614
| -3% | -$635 |
|
|
SGMO
2358
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $22.6K | ﹤0.01% |
33,545
+5,215
| +18% | +$2.81K |
|
2359
Allogene Therapeutics
ALLO
$711M
| $21.8K | ﹤0.01% |
17,612
-212
| -1% | -$253 |
|
2360
Rekor Systems
REKR
$92.2M
| $21.7K | ﹤0.01% |
13,801
+436
| +3% | +$551 |
|
2361
iShares Russell 1000 ETF
IWB
$50.2B
| $21.5K | ﹤0.01% |
59
+4
| +7% | +$1.41K |
|
2362
Invivyd
IVVD
$200M
| $21K | ﹤0.01% |
+19,077
| New | +$16.9K |
|
2363
Accuray
ARAY
$35M
| $20.7K | ﹤0.01% |
12,407
+717
| +6% | +$1.06K |
|
2364
W&T Offshore
WTI
$578M
| $20.5K | ﹤0.01% |
11,251
-423
| -4% | -$751 |
|
|
FFAI
2365
Faraday Future Intelligent Electric
FFAI
$10.9M
| $20.4K | ﹤0.01% |
105
+32
| +44% | +$10.1K |
|
2366
Aclaris Therapeutics
ACRS
$864M
| $20.2K | ﹤0.01% |
10,628
-376
| -3% | -$656 |
|
2367
SELLAS Life Sciences
SLS
$2.22B
| $19.1K | ﹤0.01% |
11,870
+223
| +2% | +$397 |
|
|
OLPX
2368
DELISTED
Olaplex Holdings
OLPX
| $18.3K | ﹤0.01% |
13,991
-609
| -4% | -$873 |
|
2369
BRC Inc
BRCC
$217M
| $17.9K | ﹤0.01% |
+11,478
| New | +$18.4K |
|
2370
MaxCyte
MXCT
$127M
| $17.8K | ﹤0.01% |
11,238
-441
| -4% | -$766 |
|
2371
Chegg
CHGG
$96.2M
| $17.6K | ﹤0.01% |
11,634
-163
| -1% | -$229 |
|
2372
Hain Celestial
HAIN
$54.2M
| $16.1K | ﹤0.01% |
10,205
-362
| -3% | -$617 |
|
2373
OmniAb
OABI
$490M
| $16.1K | ﹤0.01% |
10,071
-1,698
| -14% | -$3.1K |
|
2374
Fate Therapeutics
FATE
$321M
| $15.9K | ﹤0.01% |
12,600
-170
| -1% | -$183 |
|
2375
Advantage Solutions
ADV
$363M
| $15.4K | ﹤0.01% |
402
-13
| -3% | -$541 |
|
Similar funds
VGA
Victory Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Victory Capital Management held 2,569 positions worth $171B, up 10% from $155B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Victory Capital Management's Q3 2025 filing shows 93 new, 922 increased, 1,343 reduced and 155 closed positions. Its largest new stake was iShares Expanded Tech Sector ETF: 622,314 shares worth $78.4M. The largest sale was Oracle, an estimated $502M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
- Victory Capital Management's largest Q3 2025 buy was iShares Expanded Tech Sector ETF: 622,314 shares worth $78.4M.
- Victory Capital Management added most to Synopsys in Q3 2025, an estimated $1.13B increase.
- Victory Capital Management's biggest Q3 2025 reduction was Oracle, cutting an estimated $502M.
- Victory Capital Management fully exited Juniper Networks in Q3 2025, selling an estimated $67.7M.
- Victory Capital Management's ten largest holdings make up 24% of its $171B portfolio in Q3 2025.
- Victory Capital Management opened 93 new positions and closed 155 in Q3 2025.
- Victory Capital Management's portfolio value rose 10% quarter-over-quarter to $171B.
Based on Victory Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.